Alphatec Holdings Inc

ATEC.US
Healthcare · Medical Devices
9.32
+0.65 (+7.50%)
USD · NASDAQ

Company Information

Company Name
Alphatec Holdings Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US02081G2012
CIK: 0001350653
CUSIP: 02081G102
Currency: USD
Full Time Employees: 913
Phone: 760 431 9286
Fiscal Year End: December
IPO Date: Jun 02, 2006
Description:

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Address:

1950 Camino Vida Roble, Carlsbad, CA, United States, 92008

People

Directors & Officers

Name Title Year Born
Mr. Patrick S. Miles Chairman, CEO & President 1966
Mr. J. Todd Koning Executive VP & CFO 1973
Mr. Scott Lish Chief Operating Officer 1981
Mr. David P. Sponsel Executive Vice President of Sales 1979
Mr. Craig E. Hunsaker Executive Vice President of People & Culture 1964
Mr. Robert Judd VP of Finance and Investor Relations & Controller NA
Mr. Tyson Eliot Marshall General Counsel & Corporate Secretary 1974
Mr. Ali Shorooghi Senior Vice President of Marketing 1986
Mr. Jonathan Allen Executive Vice President of Commercial Operations 1960
Dr. Luiz Pimenta M.D., Ph.D. Chief Medical Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 13, 2026 Scott Lish N/A Sale 260.54K $12.30 $3.20M
Mar 11, 2026 David Sponsel N/A Sale 163.45K $12.52 $2.05M
Mar 09, 2026 Craig E Hunsaker N/A Sale 82.77K $12.45 $1.03M
Mar 06, 2026 Craig E Hunsaker N/A Sale 33.60K $12.22 $410.62K
Mar 05, 2026 Tyson Eliot Marshall N/A Sale 88.84K $12.49 $1.11M
Feb 05, 2026 David Sponsel N/A Sale 60.43K $13.79 $833.26K
Feb 03, 2026 Craig E Hunsaker N/A Sale 37.36K $14.71 $549.54K
Jan 05, 2026 Patrick Miles N/A Sale 100.00K $21.01 $2.10M
Dec 16, 2025 David R Pelizzon N/A Sale 250.00K $19.66 $4.92M
Dec 16, 2025 Scott Lish N/A Sale 19.90K $19.64 $390.84K
Dec 11, 2025 David M Demski N/A Sale 30.00K $21.20 $636.00K
Dec 10, 2025 Craig E Hunsaker N/A Sale 32.58K $20.84 $679.05K
Dec 10, 2025 David Sponsel N/A Sale 21.11K $20.79 $438.79K
Dec 09, 2025 Squadron Capital Llc N/A Sale 28.83K $21.03 $606.38K
Dec 09, 2025 Jennifer N Pritzker N/A Sale 28.83K $21.03 $606.38K
Dec 09, 2025 David R Pelizzon N/A Sale 28.83K $21.03 $606.38K
Dec 08, 2025 Squadron Capital Llc N/A Sale 221.17K $21.20 $4.69M
Dec 08, 2025 David R Pelizzon N/A Sale 221.17K $21.20 $4.69M
Dec 08, 2025 David Sponsel N/A Sale 988.00 $21.45 $21.19K
Dec 08, 2025 Jennifer N Pritzker N/A Sale 221.17K $21.20 $4.69M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 10.09M Mar 31, 2026 6.56% $0.00 -0.68%
Vanguard Group Inc 6.88M Dec 31, 2025 4.48% $0.00 1.01%
American Century Companies Inc 6.42M Mar 31, 2026 4.18% $0.04 -1.30%
Vanguard Capital Management, LLC 4.91M Mar 31, 2026 3.20% $0.00 0.00%
Royal Bank of Canada 4.52M Mar 31, 2026 2.94% $0.01 -8.06%
BNP Paribas Investment Partners SA 3.62M Mar 31, 2026 2.35% $0.05 13.84%
State Street Corp 3.03M Mar 31, 2026 1.97% $0.00 4.91%
Geode Capital Management, LLC 2.91M Mar 31, 2026 1.89% $0.00 2.77%
Nuveen, LLC 2.85M Mar 31, 2026 1.85% $0.01 -0.85%
Millennium Management LLC 2.81M Mar 31, 2026 1.83% $0.01 26.22%
Bank of America Corp 2.56M Mar 31, 2026 1.67% $0.00 26.91%
Point72 Asset Management, L.P. 2.49M Mar 31, 2026 1.62% $0.03 126.71%
Next Century Growth Investors LLC 2.37M Mar 31, 2026 1.54% $1.87 -1.98%
Hood River Capital Management LLC 2.30M Mar 31, 2026 1.50% $0.25 102.13%
Tremblant Capital Group 2.19M Mar 31, 2026 1.43% $0.77 34.90%
BRAIDWELL LP 2.17M Mar 31, 2026 1.41% $0.79 0.00%
Two Sigma Investments LLC 2.04M Mar 31, 2026 1.33% $0.02 3.79%
UBS Group AG 1.94M Mar 31, 2026 1.27% $0.00 37.93%
Oberweis Asset Management Inc 1.91M Mar 31, 2026 1.24% $0.61 90.75%
HPM Partners LLC 1.82M Mar 31, 2026 1.18% $0.03 -0.19%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Century U.S. Small Cap Growth 4.90M 3.19% ▲ 0.00% Jun 30, 2026
2 American Century Small Cap Growth Inv 4.90M 3.19% ▲ 0.00% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 3.65M 2.37% ▲ 1.52% Jun 30, 2026
4 iShares Russell 2000 ETF 3.24M 2.11% ▲ 0.60% Jun 30, 2026
5 Vanguard Mid Cap Growth Inv 1.89M 1.23% ▲ 0.00% Mar 31, 2026
6 BNP Paribas Health Cr Innovtr Cl Cap 1.57M 1.02% ▼ 0.05% May 31, 2026
7 BNP Paribas US Small Cap ClassicC 1.57M 1.02% ▼ 0.58% May 31, 2026
8 Hood River Small-Cap Growth Instl 1.51M 0.98% ▲ 111.90% Mar 31, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 1.36M 0.88% ▲ 4.81% Jun 30, 2026
10 CREF Total Global Stock Account R3 1.32M 0.86% ▼ 15.84% May 31, 2026

Financial Highlights

Market Cap: $1.43B
EBITDA: $28.40M
PEG Ratio: $0.48
Book Value: $-0.04
Earnings/Share: $-0.89
Profit Margin: -15.93%
Operating Margin: -11.48%
ROA (TTM): -3.81%
ROE (TTM): -630.66%
Revenue (TTM): $787.08M
Revenue/Share (TTM): $5.18
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 13.60%

Valuation Metrics

Enterprise Value: $1.80B
Trailing P/E: 0.00
Forward P/E: 344.83

Shares Statistics

Shares Outstanding: 153.79M
Shares Float: 121.52M
% Insiders: 2,046.90%
% Institutions: 7,782.30%
Short % Float: 10.32%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$764.16M
Cost of Goods Sold
adjust
$-232.27M
Gross Profit
subtotal
$531.89M
SG&A
adjust
$-498.53M
R&D
adjust
$-76.27M
Other Operating Expense
adjust
$-39.22M
Operating Income
subtotal
$-82.13M
Other / Non-Operating Items
adjust
$-61.23M
Net Income
subtotal
$-143.36M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ATEC.US!